These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26041885)

  • 1. Dynamic self-guiding analysis of Alzheimer's disease.
    Kurakin A; Bredesen DE
    Oncotarget; 2015 Jun; 6(16):14092-122. PubMed ID: 26041885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders.
    Cataldo A; Rebeck GW; Ghetri B; Hulette C; Lippa C; Van Broeckhoven C; van Duijn C; Cras P; Bogdanovic N; Bird T; Peterhoff C; Nixon R
    Ann Neurol; 2001 Nov; 50(5):661-5. PubMed ID: 11706973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retromers in Alzheimer's disease.
    Siegenthaler BM; Rajendran L
    Neurodegener Dis; 2012; 10(1-4):116-21. PubMed ID: 22398391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production.
    Pastorino L; Sun A; Lu PJ; Zhou XZ; Balastik M; Finn G; Wulf G; Lim J; Li SH; Li X; Xia W; Nicholson LK; Lu KP
    Nature; 2006 Mar; 440(7083):528-34. PubMed ID: 16554819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular neuropathology of Alzheimer's disease.
    Masters CL; Beyreuther K
    Arzneimittelforschung; 1995 Mar; 45(3A):410-2. PubMed ID: 7763335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease.
    Sahlin C; Pettersson FE; Nilsson LN; Lannfelt L; Johansson AS
    Eur J Neurosci; 2007 Aug; 26(4):882-9. PubMed ID: 17714184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A domain level interaction network of amyloid precursor protein and Abeta of Alzheimer's disease.
    Perreau VM; Orchard S; Adlard PA; Bellingham SA; Cappai R; Ciccotosto GD; Cowie TF; Crouch PJ; Duce JA; Evin G; Faux NG; Hill AF; Hung YH; James SA; Li QX; Mok SS; Tew DJ; White AR; Bush AI; Hermjakob H; Masters CL
    Proteomics; 2010 Jun; 10(12):2377-95. PubMed ID: 20391539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic mechanisms in Alzheimer's disease.
    Pastorino L; Lu KP
    Eur J Pharmacol; 2006 Sep; 545(1):29-38. PubMed ID: 16904664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
    Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
    Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease.
    Grimm MO; Kuchenbecker J; Rothhaar TL; Grösgen S; Hundsdörfer B; Burg VK; Friess P; Müller U; Grimm HS; Riemenschneider M; Hartmann T
    J Neurochem; 2011 Mar; 116(5):916-25. PubMed ID: 21214572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolipids: critical players in Alzheimer's disease.
    van Echten-Deckert G; Walter J
    Prog Lipid Res; 2012 Oct; 51(4):378-93. PubMed ID: 22835784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium and neuronal injury in Alzheimer's disease. Contributions of beta-amyloid precursor protein mismetabolism, free radicals, and metabolic compromise.
    Mattson MP
    Ann N Y Acad Sci; 1994 Dec; 747():50-76. PubMed ID: 7847692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA networks surrounding APP and amyloid-β metabolism--implications for Alzheimer's disease.
    Schonrock N; Matamales M; Ittner LM; Götz J
    Exp Neurol; 2012 Jun; 235(2):447-54. PubMed ID: 22119426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.
    Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A
    J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.
    Mann DM; Iwatsubo T; Ihara Y; Cairns NJ; Lantos PL; Bogdanovic N; Lannfelt L; Winblad B; Maat-Schieman ML; Rossor MN
    Am J Pathol; 1996 Apr; 148(4):1257-66. PubMed ID: 8644866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of APP interaction proteins by DUALmembrane yeast two-hybrid system.
    Yu Y; Li Y; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(3):2802-8. PubMed ID: 26045787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular basics of Alzheimer's disease].
    Grigorenko AP; Rogaev EI
    Mol Biol (Mosk); 2007; 41(2):331-45. PubMed ID: 17514900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's amyloid precursor protein-positive degenerative neurites exist even within kuru plaques not specific to Alzheimer's disease.
    Ohgami T; Kitamoto T; Weidmann A; Beyreuther K; Tateishi J
    Am J Pathol; 1991 Dec; 139(6):1245-50. PubMed ID: 1684265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.